TOVX logo

Theriva Biologics (TOVX) Non Current Assets

Annual Non Current Assets

$27.82 M
+$1.48 M+5.60%

31 December 2023

TOVX Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$20.57 M
-$2.10 M-9.26%

01 September 2024

TOVX Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TOVX Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+5.6%-23.2%
3 y3 years+5743.7%+1265.3%
5 y5 years+3338.3%+2443.3%

TOVX Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+5743.7%-30.1%+1265.3%
5 y5 yearsat high+5743.7%-30.1%+4822.3%
alltimeall timeat high>+9999.0%-30.1%

Theriva Biologics Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$20.57 M(-9.3%)
June 2024
-
$22.68 M(-16.2%)
Mar 2024
-
$27.07 M(-2.7%)
Dec 2023
$27.40 M(-39.8%)
$27.82 M(+3.9%)
Sept 2023
-
$26.78 M(-2.6%)
June 2023
-
$27.48 M(-0.4%)
Mar 2023
-
$27.59 M(+4.7%)
Dec 2022
$45.52 M(-33.9%)
$26.34 M(+1.5%)
Sept 2022
-
$25.96 M(-5.4%)
June 2022
-
$27.44 M(-6.8%)
Mar 2022
-
$29.45 M(+1853.9%)
Dec 2021
$68.86 M(+767.9%)
-
Dec 2021
-
$1.51 M(-3.6%)
Sept 2021
-
$1.56 M(-3.6%)
June 2021
-
$1.62 M(+288.3%)
Mar 2021
-
$418.00 K(-12.2%)
Dec 2020
$7.93 M(-51.7%)
$476.00 K(-12.0%)
Sept 2020
-
$541.00 K(-13.6%)
June 2020
-
$626.00 K(-12.8%)
Mar 2020
-
$718.00 K(-11.2%)
Dec 2019
$16.43 M(-44.3%)
$809.00 K(-10.0%)
Sept 2019
-
$899.00 K(-9.1%)
June 2019
-
$989.00 K(-8.3%)
Mar 2019
-
$1.08 M(+71.1%)
Dec 2018
$29.51 M(+64.5%)
$630.00 K(-8.4%)
Sept 2018
-
$688.00 K(-8.8%)
June 2018
-
$754.00 K(-8.5%)
Mar 2018
-
$824.00 K(-7.9%)
Dec 2017
$17.94 M(-16.8%)
$895.00 K(-7.3%)
Sept 2017
-
$966.00 K(+17.2%)
June 2017
-
$824.00 K(-6.6%)
Mar 2017
-
$882.00 K(-5.0%)
Dec 2016
$21.57 M(-28.9%)
$928.00 K(+52.6%)
Sept 2016
-
$608.00 K(+19.7%)
June 2016
-
$508.00 K(-3.6%)
Mar 2016
-
$527.00 K(+3.7%)
Dec 2015
$30.34 M(+59.1%)
$508.00 K(+2.2%)
Sept 2015
-
$497.00 K(+297.6%)
June 2015
-
$125.00 K(+34.4%)
Mar 2015
-
$93.00 K(+31.0%)
Dec 2014
$19.07 M(+17.6%)
$71.00 K(-2.7%)
Sept 2014
-
$73.00 K(+28.1%)
June 2014
-
$57.00 K(+29.5%)
Mar 2014
-
$44.00 K(+7.3%)
Dec 2013
$16.22 M(+30.1%)
$41.00 K(-74.5%)
Sept 2013
-
$161.00 K(-5.3%)
June 2013
-
$170.00 K(-26.1%)
Mar 2013
-
$230.00 K(-76.0%)
Dec 2012
$12.46 M(+75.0%)
$960.00 K(-1.6%)
Sept 2012
-
$976.00 K(+0.2%)
June 2012
-
$974.00 K(-4.9%)
Mar 2012
-
$1.02 M(+189.3%)
Dec 2011
$7.12 M
$354.00 K(-39.2%)
Sept 2011
-
$582.00 K(-5.3%)
June 2011
-
$614.70 K(-1.1%)
DateAnnualQuarterly
Mar 2011
-
$621.50 K(+9.8%)
Dec 2010
$3.54 M(+28.7%)
$566.00 K(-42.2%)
Sept 2010
-
$979.00 K(-9.8%)
June 2010
-
$1.09 M(-9.6%)
Mar 2010
-
$1.20 M(-9.1%)
Dec 2009
$2.75 M(-53.5%)
$1.32 M(-6.8%)
Sept 2009
-
$1.42 M(+16.3%)
June 2009
-
$1.22 M(-9.0%)
Mar 2009
-
$1.34 M(-8.2%)
Dec 2008
$5.93 M(-48.7%)
$1.46 M(-14.8%)
Sept 2008
-
$1.71 M(-9.6%)
June 2008
-
$1.89 M(-5.2%)
Mar 2008
-
$2.00 M(-3.9%)
Dec 2007
$11.56 M(-5.4%)
$2.08 M(+6.5%)
Sept 2007
-
$1.95 M(+25.1%)
June 2007
-
$1.56 M(+149.1%)
Mar 2007
-
$625.30 K(+110.3%)
Dec 2006
$12.22 M(+955.3%)
$297.30 K(-55.6%)
Dec 2005
$1.16 M(+38.6%)
-
Mar 2003
-
$669.90 K(-1.4%)
Dec 2002
$835.30 K(-39.2%)
$679.30 K(-6.5%)
Sept 2002
-
$726.80 K(+0.0%)
June 2002
-
$726.60 K(+7.1%)
Mar 2002
-
$678.60 K(-0.7%)
Dec 2001
$1.37 M(-72.0%)
$683.40 K(+13.1%)
Sept 2001
-
$604.30 K(-6.2%)
June 2001
-
$644.00 K(+22.7%)
Mar 2001
-
$524.70 K(-3.0%)
Dec 2000
$4.91 M(+8.2%)
$541.00 K(+1.6%)
Sept 2000
-
$532.60 K(+11.8%)
June 2000
-
$476.40 K(-8.2%)
Mar 2000
-
$518.70 K(+1.8%)
Dec 1999
$4.54 M(+74.6%)
$509.60 K(+69.9%)
Sept 1999
-
$300.00 K(+50.0%)
June 1999
-
$200.00 K(0.0%)
Mar 1999
-
$200.00 K(-23.8%)
Dec 1998
$2.60 M(+420.0%)
$262.50 K(+31.3%)
Sept 1998
-
$200.00 K(+100.0%)
June 1998
-
$100.00 K(0.0%)
Mar 1998
-
$100.00 K(-50.0%)
Dec 1997
$500.00 K(-80.0%)
$200.00 K(0.0%)
Sept 1997
-
$200.00 K(-33.3%)
June 1997
-
$300.00 K(+50.0%)
Mar 1997
-
$200.00 K(-33.3%)
Dec 1996
$2.50 M(+25.0%)
$300.00 K(0.0%)
Sept 1996
-
$300.00 K(-40.0%)
June 1996
-
$500.00 K(+25.0%)
Mar 1996
-
$400.00 K(+100.0%)
Dec 1995
$2.00 M(+1900.0%)
$200.00 K(+100.0%)
Sept 1995
-
$100.00 K(-66.7%)
Dec 1994
$100.00 K(-94.1%)
$300.00 K(+200.0%)
Mar 1994
-
$100.00 K(0.0%)
Dec 1993
$1.70 M
$100.00 K(>+9900.0%)
Sept 1993
-
$0.00(0.0%)
June 1993
-
$0.00(0.0%)
Mar 1993
-
$0.00

FAQ

  • What is Theriva Biologics annual long term assets?
  • What is the all time high annual non current assets for Theriva Biologics?
  • What is Theriva Biologics annual non current assets year-on-year change?
  • What is Theriva Biologics quarterly long term assets?
  • What is the all time high quarterly non current assets for Theriva Biologics?
  • What is Theriva Biologics quarterly non current assets year-on-year change?

What is Theriva Biologics annual long term assets?

The current annual non current assets of TOVX is $27.82 M

What is the all time high annual non current assets for Theriva Biologics?

Theriva Biologics all-time high annual long term assets is $27.82 M

What is Theriva Biologics annual non current assets year-on-year change?

Over the past year, TOVX annual long term assets has changed by +$1.48 M (+5.60%)

What is Theriva Biologics quarterly long term assets?

The current quarterly non current assets of TOVX is $20.57 M

What is the all time high quarterly non current assets for Theriva Biologics?

Theriva Biologics all-time high quarterly long term assets is $29.45 M

What is Theriva Biologics quarterly non current assets year-on-year change?

Over the past year, TOVX quarterly long term assets has changed by -$6.20 M (-23.16%)